MedTrace Logo

Metabolomic Profiling Based on Nuclear Magnetic Resonance in Fibromyalgia Patients

NCT06725199 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-12-10

No results posted yet for this study

Summary

Evaluation of sera of fibromyalgia patients in terms of energy metabolism function and possible alterations in metabolism predisposing to various degenerative/proliferative diseases.

Conditions

  • Patients with Clinical Complaints of Fibromyalgia Among the Patients Applying to the Outpatient Clinic
  • Fibromyalgia Syndrome

Sponsors & Collaborators

  • University of Beykent

    collaborator OTHER

  • Bezmialem Vakif University

    collaborator OTHER

  • hatice kübra aşık

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2024-12-01
Completion
2025-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06725199 on ClinicalTrials.gov